Morocco latest patents query
The latest invention patents collect the data information of Morocco invention patents from 2000 to 2024, typesetting according to the date of patent publication, including patent number, application date, invention Bibliographic data, abstracts, and specification data of people are convenient for scientific researchers to quickly browse and search for patents.
Bird feed and in particular poultry feed, comprising synthetic capsaicinoid derivatives and such feed for prohylactic use or treatment of salmonella infection
UndeterminedMA43441A
Owner:AXICHEM
SIDE END CAP CONFIGURATION FOR AN ARTICULATED WIND TURBINE BLADE
UndeterminedMA53949A
Owner:GENERAL ELECTRIC CO
USEFULNESS OF A PROTEIN IN PREDICTING IN VIVO EFFECTS
UndeterminedMA41048A
Owner:QUALYST TRANSPORTER SOLUTIONS LLC
Fully automated stationary encapsulation and placement of support components
UndeterminedMA71314A
Owner:LISA DRÄXLMAIER GMBH
2,3-DIHYDRO-1H-PYRROLO[3,4-C]PYRIDIN-1-ONE DERIVATIVES SERVING AS HPK1 INHIBITORS FOR CANCER TREATMENT
InactiveMA54223A
Owner:PFIZER INC
MIC-1 AND GLP-1 INTENDED FOR USE IN THE TREATMENT OF OBESITY
UndeterminedMA50233A
Owner:NOVO NORDISK AS
TYPE I AND TYPE II RECEPTOR HETEROMULTIMERS OF THE TGF-BETA SUPERFAMILY AND THEIR USES
UndeterminedMA41916A
Owner:ACCELERON PHARMA INC
Glazing comprising at least one profile bead for joining two panes of glass, and a pane of glass for such glazing
UndeterminedMA49282A
Owner:SAINT GOBAIN VITRAGE SA
METHOD FOR THE MANUFACTURE OF CONTAINERS FOR COSMETIC PRODUCTS
UndeterminedMA46950A
Owner:O M Z OFFICINA MECCANICA ZANOTTI SPA
Benzopyrane and imidazole stabilization derivatives used for stabilizing light chains of amyloidogenic immunoglobulins
UndeterminedMA55524A
Owner:THE SCRIPPS RES INST
Compositions containing substitute compounds of [1,2,4]triazolo[1,5-A]pyrimidine-7-yl used as PDE2 inhibitors
UndeterminedMA50375A
Owner:DART NEUROSCIENCE (CAYMAN) LTD(GB)
Tetraspecific and bispecific tetravalent antigen-binding proteins and their uses
UndeterminedMA42821A
Owner:AMGEN INC
METHOD FOR PREPARING PHARMACEUTICAL COMPOSITIONS CONTAINING AMPHIPHILIC ACTIVE INGREDIENTS
UndeterminedMA56024A
Owner:PHARMADEV SA
HIGH-FLOW PROCESS FOR DETECTING, PREVENTING AND REMOVING STAINS ON TEETH
UndeterminedMA51011A
Owner:JOHNSON & JOHNSON CONSUMER INC
POWER LINE TRANSPORT DEVICE, PARTICULARLY FOR CABLES TO BE PROCESSED IN CABLE MACHINING MACHINES
UndeterminedMA41479A
Owner:SCHLEUNIGER HOLDING AG
INDAZOLE-3-CARBOXAMIDES SUBSTITUTED BY HETEROARYL AT POSITION 5, PREPARATION AND ASSOCIATED USE
UndeterminedMA51908A
Owner:SAMUMED LLC
METHOD AND SYSTEM FOR EXTRACTING OIL FROM A RAW MATERIAL CONTAINING OIL
UndeterminedMA55476A
Owner:ALFA LAVAL CORP AB
GLAZING WITH ELECTRICALLY CONDUCTIVE ELEMENT AND ITS ELECTRICAL CONNECTION
UndeterminedMA45720A
Owner:SAINT GOBAIN VITRAGE SA
ISOMERIZATION OF TERMINAL GROUPS OF POLY(ALKYLENE CARBONATE) POLYMERS
UndeterminedMA52294A
Owner:SAUDI ARAMCO TECH CO
Thiophene derivatives for the treatment of disorders caused by IgE
UndeterminedMA52941A
Owner:UCB BIOPHARMA SPRL
Sintering press for sintering electronic components onto a substrate
UndeterminedMA54524A
Owner:AMX AUTOMATRIX SRL
HETEROBICYCLIC COMPOUNDS USEFUL AS MODULATORS OF IL-12, IL-23 AND / OR IFN ALPHA RESPONSES
UndeterminedMA46620A
Owner:BRISTOL MYERS SQUIBB CO
THERAPEUTIC AND DIAGNOSTIC METHODS FOR MAST CELL-MEDIATED INFLAMMATORY DISEASES
UndeterminedMA51741A
Owner:F HOFFMANN LA ROCHE & CO AG
NICOTINAMIDE RECOVERY PATHWAY INHIBITOR CONJUGATES: ADENINE QUATERNARISED DINUCLEOTIDE
UndeterminedMA51189A
Owner:SEAGEN INC
CELL CULTURE PROCESSES AND COMPOSITIONS FOR ANTIBODY PRODUCTION
UndeterminedMA56130A
Owner:TAKEDA PHARMA CO LTD
A product based on mussel protein with adhesive action and its application to inhibit dermatomyositis
UndeterminedMA42466A
Owner:JIANGYIN BENGT I SAMUELSSON INSTITUTE OF LIFE SCIENCE CO LTD
Nutraceutical and / or food product of the Savoy biscuit type and its method of obtaining it from food ingredients
UndeterminedMA39646A
Owner:NBREAD PROCESS
METHODS OF USING A BISPECIFIC ANTIBODY THAT RECOGNIZES COAGULATION FACTOR IX AND / OR ACTIVATED COAGULATION FACTOR IX AND COAGULATION FACTOR X AND / OR ACTIVATED COAGULATION FACTOR X
UndeterminedMA46200A
Owner:CHUGAI PHARMA CO LTD +1
METHOD AND DEVICE FOR MAINTAINING A BELT CONVEYOR, CORRESPONDING ASSEMBLY
UndeterminedMA47026A
Owner:BRUNONE RENE
CHARGING CIRCUIT AND MOBILE TERMINAL
Owner:GUANGDONG OPPO MOBILE TELECOMMUNICATIONS CORP LTD
LIQUID ALLERGEN COMPOSITIONS AND THEIR MANUFACTURING PROCESSES
UndeterminedMA46920A
Owner:BEFORE BRANDS INC
MONO- AND DIAMIDINE ENDO-EXONUCLEASE INHIBITORS AND METHODS FOR INHIBITING ENDO-EXONUCLEASE ACTIVITY
UndeterminedMA51151A
Owner:MONTDOREX INC
DNA COLLECTION SHEET AND METHOD OF EXTRACTION, PURIFICATION AND SEQUENCED DNA
UndeterminedMA52904A
Owner:BLANCO SERGIO +1
MODULATION OF THE IMMUNE RESPONSE USING ANTIBODY-DRUG CONJUGATES
UndeterminedMA50369A
Owner:SEAGEN INC
PROCESS FOR RECOVERING PHOSPHORIC ACID FROM SOLID PHOSPHORUS SOURCES
UndeterminedMA55012A
Owner:THE UNIV OF AMSTERDAM
Vaccines against pathogens and their production and use processes
UndeterminedMA44252A
Owner:PRESIDENT & FELLOWS OF HARVARD COLLEGE
GLASS PRODUCT WITH A CORRESPONDING MARKING AND PREPARATION PROCESS
UndeterminedMA55324A
Owner:SAINT GOBAIN VITRAGE SA
NEW PROCESSES AND INTERMEDIATES FOR THE PREPARATION OF SOLUBLE GUANYLATE CYCLASE STIMULATORS
UndeterminedMA51565A
Owner:CYCLERION THERAPEUTICS INC
PYRIDINONE DERIVATIVES AND THEIR USE AS SELECTIVE ALK-2 INHIBITORS
UndeterminedMA50782A
Owner:NOVARTIS AG
METHOD FOR MANUFACTURED A DECORATIVE PANEL AND THE DECORATIVE PANEL THUS OBTAINED
UndeterminedMA71472A
Owner:UNILIN BV
TYROSINE ANALOGUE DERIVATIVES AS RHO-KINASE INHIBITORS
UndeterminedMA50074A
Owner:CHIESI FARMACEUTICI SPA
SELECTIVE INHIBITORS OF ARGININE PROTEIN METHYLTTRANSFERASE 5 (PRMT5)
UndeterminedMA49840A
Owner:PRELUDE THERAPEUTICS INC
ANTIBODY PURIFICATION PROCESSES AND ASSOCIATED COMPOSITIONS
UndeterminedMA56132A
Owner:TAKEDA PHARMA CO LTD
METHOD FOR DETERMINING THE CURVEMENT OF A GLASS PLATE, IN PARTICULAR A WINDSHIELD
UndeterminedMA53477A
Owner:NOKRA OPTISCHE PRUFTECHN & AUTOMATION
THERMOCHEMICAL REACTOR SYSTEM AND SOLAR INSTALLATION WITH A THERMOCHEMICAL REACTOR SYSTEM
UndeterminedMA71312A
Owner:DEUTSCHES ZENTRUM FÜR LUFT UND RAUMFAHRT E V
Compounds and methods for inhibiting histone demethylases
UndeterminedMA40470A
Owner:GILEAD SCIENCES INC
C-MANNOSIDE COMPOUNDS USEFUL FOR THE TREATMENT OF URINARY TRACT INFECTIONS
ActiveMA53135A
Owner:GLAXOSMITHKLINE INTPROP DEV LTD +1
Compositions and processes for treating bruises and rejuvenating the skin
UndeterminedMA55906A
Owner:ALASTIN SKINCARE INC
COMPOUNDS OF 4,4 A, 5,7-TETRAHYDRO-3 H-FURO [3,4-B]PYRIDINYL
UndeterminedMA46698A
Owner:JANSSEN PHARMA NV
COMBINATION OF PROTEASOME INHIBITORS AND ANTI-CD30 ANTIBODIES
UndeterminedMA45862A
Owner:MILLENNIUM PHARMACEUTICALS INC
Nitrogen Oxide Absorbing Suspension, its Preparation Process and its Method of Use
UndeterminedMA56158A
Owner:HUANG LIWEI
NEW CONTINUOUS FLOW REACTOR FOR LOW PH VIRAL INACTIVATION
UndeterminedMA53856A
Owner:BOEHRINGER INGELHEIM INT GMBH
BUFFER STORAGE ARRANGEMENT FILLED WITH PHASE CHANGE MATERIAL
UndeterminedMA52578A
Owner:HEATVENTORS KFT
METHOD FOR PREPARING HORMONE RECEPTOR MODULATORS FOR THE TREATMENT OF METABOLIC CONDITIONS AND DISORDERS
UndeterminedMA55632A
Owner:ARDELYX INC
Use of a dicarboxylic acid to control the growth of holoparasitic or hemiparasitic plants
UndeterminedMA39892A
Owner:CENT NAT DE LA RECH SCI (C N R S) +3
MATERIALS AND METHODS FOR TREATING AUTOSOMAL DOMINANT CONE AND ROD DYSTROPHY
UndeterminedMA51186A
Owner:BAYER HEALTHCARE LLC +1
COMBINATION OF PD-1 AND LAG-3 INHIBITORS FOR IMPROVED EFFICACY IN CANCER TREATMENT
UndeterminedMA55965A
Owner:REGENERON PHARMACEUTICALS INC
ADDITIVE THAT ENHANCES THE EFFECTIVENESS OF PIG MANURE AS A FERTILIZER
UndeterminedMA54742A
Owner:FERTINAGRO BIOTECH SL
LIGHTING DEVICE FOR A MOTOR VEHICLE CAPABLE OF CREATING AN OPTICAL EFFECT KNOWN AS MOIRE
UndeterminedMA71360A
Owner:MARELLI AUTOMOTIVE LIGHTING FRANCE
PYRIMIDIN-2-YLAMINO-1H-PYRAZOLS AS LRRK2 INHIBITORS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS
ActiveMA45389A
Owner:DENALI THERAPEUTICS INC
IMMUNOGENEOUS PRODUCT COMPRISING IL-4 AND / OR IL-13 FOR THE TREATMENT OF DISORDERS ASSOCIATED WITH ABERRANT IL-4 AND / OR IL-13 EXPRESSION OR ACTIVITY
UndeterminedMA52748A
Owner:INST NAT DE LA SANTE & DE LA RECHERCHE MEDICALE (INSERM) +2
PHARMACEUTICAL COMPOSITIONS AND DOSAGE REGIMEN FOR CLINICAL USE OF ANTI-ANTIGEN 2 ANTIBODIES OF BLOOD DENDRITIC CELLS
UndeterminedMA44763A
Owner:BIOGEN MA INC
SOLAR RADIATION CONCENTRATION DEVICE EQUIPPED WITH AN INFLATABLE CONCENTRATOR CUSHION
UndeterminedMA40854A
Owner:HELIOVIS
ALPHA-2C SUBTYPE ALPHA-2 ADRENERGIC RECEPTOR ANTAGONISTS FOR THE TREATMENT OF SLEEP APNEA
UndeterminedMA53711A
Owner:BAYER AG
Variants of TGF-BETA R2 endonuclease, compositions and methods of use
UndeterminedMA46543A
Owner:BLUEBIRD BIO INC
THERAPEUTIC COMBINATIONS INCLUDING ANTI-CD123 IMMUNOCONJUGATES
UndeterminedMA55816A
Owner:IMMUNOGEN INC
USE OF BIOMARKERS IN THE IDENTIFICATION OF CANCER PATIENTS SENSITIVE TO TREATMENT WITH A PRMT5 INHIBITOR
UndeterminedMA47594A
Owner:JANSSEN PHARMA NV
TREATMENT METHODS FOR UTERINE FIBROIDS AND ENDOMETRIOSIS
ActiveMA46362Atighter distributionminimizing side-effects
Owner:TAKEDA PHARMA CO LTD +1
LAMINATED GLASS FOR THE IMPLEMENTATION OF A HUD FUNCTION
UndeterminedMA49020A
Owner:SAINT GOBAIN VITRAGE SA
HETEROCYCLIC COMPOUNDS FUMAGILLOL, AND CORRESPONDING PROCESSES OF MANUFACTURE AND USE
UndeterminedMA42612A
Owner:ZAFGEN INC
PROCESSES AND COMPOSITIONS OF ISOINDOLINE-1,3-DIONE AND ISOINDOLE MEDICINES USEFUL FOR THE TREATMENT OF CANCER, ULCERATIVE COLITIS AND ASSOCIATED INFLAMMATORY DISEASES
UndeterminedMA52266A
Owner:AMGEN (EURO) GMBH
Regulated expression of transgenes using closed-ended DNA vectors (CEDNA)
UndeterminedMA51915A
Owner:GENERATION BIO CO
HIGH-TEMPERATURE THERMAL ENERGY STORAGE SYSTEM, METHOD OF CONSTRUCTION AND METHOD OF OPERATION OF SAID STORAGE SYSTEM
Owner:ENERGYNEST AS
Human monoclonal antibodies with strong neutralizing activity against HSV-1 and HSV-2
UndeterminedMA41775A
Owner:POLICHEM SA
Fusion proteins comprising sulfoglucosamine sulfohydrolase enzymes and associated methods
UndeterminedMA71661A
Owner:DENALI THERAPEUTICS INC
ANTIBODY-DEPENDENT CELL-MEDIATED MODULATION METHODS FOR CYTOTOXICITY
UndeterminedMA53603A
Owner:AMGEN INC
DIRECT SELECTION OF CELLS EXPRESSING HIGH HETEROMERIC PROTEIN CONTENTS USING INTRAGENIC GLUTAMINE SYNTHETASE COMPLEMENTATION VECTORS
UndeterminedMA44976A
Owner:AMGEN INC
RELIABILITY IMPROVEMENT METHODS FOR A PHYSICALLY INCLONABLE FUNCTIONAL BIT STRING GENERATION
UndeterminedMA40999A
Owner:STC UNM
Anti-CD79B antibodies and methods of using said antibodies
UndeterminedMA40938A
Owner:F HOFFMANN LA ROCHE & CO AG
NEW HIGH MOLECULAR WEIGHT OF HYALURONIC ACID OR A SALT THEREOF OF VEGETABLE ORIGIN INTENDED FOR USE IN MAINTAINING JOINT HOMEOSTASIS AND PREVENTING HARMFUL OSTEOARTHRITIS PROCESSES
UndeterminedMA71555A
Owner:VIVATIS PHARMA ITALIA SRL
Remote surface sensing using guided surface wave modes on lossy media
UndeterminedMA40398A
Owner:CPG TECH LLC
PROCESS FOR THE PRODUCTION OF SUBSTITUTED 2-[2-(PHENYL)ETHYLAMINO]ALKANEAMIDE DERIVATIVES
UndeterminedMA55710A
Owner:NEWRON PHARMACEUTICALS SPA
VEHICLE DECORATIVE PART, VEHICLE GLASS ASSEMBLY AND ASSOCIATED MANUFACTURING METHOD AND MOLDING DEVICE
UndeterminedMA54194A
Owner:SAINT GOBAIN VITRAGE SA
PROCESS FOR MANUFACTURED AN ANNEILLATED STEEL SHEET BY GALVANIZING
ActiveMA50453A
Owner:ARCELORMITTAL SA
Monoclonal Anti-TRKB Antibodies and Their Methods of Use
UndeterminedMA51207A
Owner:REGENERON PHARMACEUTICALS INC